Overview

DermaLabs (governed as DermaDAO) is a decentralized-science BioDAO on the Bio Protocol launchpad that reorganizes skincare research around real-world data instead of small, one-off clinical panels. It pairs dermatologist-led formulation with a community that opts into standardized, pre-registered trials, capturing measurable skin changes through an AI-imaging app and rewarding validated data contributions with tokens (bio.xyz). It sits in the same DeSci lineage as VitaDAO and HairDAO, but occupies a distinct niche: the consumer product is the experiment.

The thesis: every bathroom mirror is a laboratory

Skincare is a $190 billion-plus global industry that still validates products on small, short, industry-funded panels — methodologically closer to marketing than to science. DermaLabs' bet is that the largest untapped dataset in dermatology is the one billions of people already generate every morning and night. By standardizing how ordinary users apply a product and photograph the result, it converts routine consumer behavior into a continuously growing longitudinal study across real climates, routines, skin tones, and adherence levels (dermadao.xyz). The product is the data-generation flywheel: buying and using the serum is how a member enters the trial.

Products and SkinScan

DermaLabs ships evidence-first consumer skincare as the on-ramp to its research loop. Its first products are Moon Drops, an evening antioxidant serum combining L-ascorbic acid, alpha-tocopherol, and ferulic acid, and Sol Drops, a daytime mineral serum with zinc oxide, titanium dioxide, niacinamide, and panthenol (bio.xyz). Both launched at $49.99 and, per Bio Protocol's ecosystem reporting, sold out their first batch within 24 hours, with each purchase crediting the buyer BioXP toward the wider Bio ecosystem.

The measurement layer is SkinScan, an AI-imaging tool that quantifies wrinkles, spots, and redness from user photos (dermadao.xyz). Standardized capture turns a selfie into a comparable data point, so a member's own before/after becomes a row in a shared, auditable dataset rather than an anecdote.

Decentralized trials and IP

DermaDAO's research arm, Skin Science Labs, runs blinded, pre-registered A/B protocols on-chain: participants follow a defined regimen, keep time-stamped photo journals, and earn $SKIN for validated contributions. Because the design is registered up front and data stays user-owned, the DAO can run stratified analyses — by diagnosis, skin tone, and age — that a single-panel study cannot. Its flagship study, the LUNAR Trial ("Longevity Using Novel Actives for Rejuvenation"), tests Moon Drops variants side by side with longitudinal tracking over weeks rather than a single endpoint (bio.xyz).

Research outputs are captured as IP tokens (IP-NFTs) — the same Molecule-pioneered primitive VitaDAO uses — so a validated finding becomes a transparent, community-owned, and fundable asset instead of a corporate trade secret (dermadao.xyz).

The science team

DermaLabs is fronted by a working dermatology and cosmetic-chemistry bench rather than a purely crypto-native team (bio.xyz):

• Dr. DTS (Hongseok Kim) — board-certified Korean dermatologist focused on evidence-based K-beauty, and the public face of the launch.
• Jez Marston — physician-scientist with a PhD in immunology and computational biology (Cornell).
• Hyeon Pyo Jhun — cosmetic chemist with 40-plus years in skincare R&D.
• Dongsinne Sohn — health and Web3 operator focused on chronic skin conditions.

The $SKIN token and place in the Bio ecosystem

$SKIN is DermaDAO's utility token: it rewards validated data and product contributions and lets holders govern research direction and funding, with no equity or revenue claim (dermadao.xyz). It launched through Bio Protocol's Ignition Sale mechanism — a Gnosis batch-auction where participants bid stablecoins for a fixed token allocation — in December 2025.

DermaLabs is one of Bio Protocol's incubated BioDAOs, alongside longevity (VitaDAO), hair loss (HairDAO), cryopreservation (CryoDAO), and quantum biology (Quantum Biology DAO). What sets it apart is going to a shipped, revenue-generating consumer product first and treating that product line as the recruitment funnel for its science — the clearest example in the BioDAO set of the "real-world DeSci product" model.

How Caper approaches this

DermaLabs and Caper answer different questions, but they meet on one: who should steer a community-funded effort, and how is that steering earned? DermaDAO rewards contribution with a freely tradeable $SKIN token — data and purchases mint governance power that can then be bought or sold on the open market. Caper takes the opposite stance on the decisive slice of control: voting on a caper mints a soulbound, non-transferable proof-of-vote token (indivisible, and locked to its holder — its deposit authority is the component itself, with updates permanently denied, per contracts/core/src/caper_dao.rs). A member's on-chain influence is compute_vote_weight = (t·v)/(V·T) in contracts/logic/src/lib.rs — their token holdings times their earned votes, over the totals — so a big bag alone can't capture control, and participation can't be purchased after the fact. The same weight sets a member's exit redemption before the vote tokens are burned. For a research DAO, the honest read is that each model optimizes for something real: $SKIN maximizes liquid, tradeable incentives to contribute data at scale, while Caper's earned, un-sellable weight is built for the case where you specifically do not want steering to be for sale.